Inhibikase Therapeutics Inc Forecast, price target & analysts
$2.07
11.29%
yesterday
Nasdaq,
Apr 11, 10:00 pm CET
Inhibikase Therapeutics Inc Target price 2025 - Analyst rating & recommendation
Powered by
Inhibikase Therapeutics Inc Classifications & Recommendation:
Buy
50%
Hold
50%
Inhibikase Therapeutics Inc Price Target
| Target Price | $8.00 |
| Price | $2.07 |
| Potential |
286.47%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Inhibikase Therapeutics Inc price target 2026.
The average Inhibikase Therapeutics Inc target price is $8.00.
This is
286.47%
register free of charge
|
|
| A rating was issued by 2 analysts: 1 Analysts recommend Inhibikase Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Inhibikase Therapeutics Inc stock has an average upside potential 2026 of
286.47%
register free of charge
|
Current Inhibikase Therapeutics Inc Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 28 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 12 2025 |
| Jefferies |
Locked
➜
Locked
|
Locked | Nov 08 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 14 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 28 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 12 2025 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Nov 08 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 14 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
